Targeted Agent Found Better than Immunomodulator as First-Line Strategy for Relapsing Multiple Sclerosis

New Data Stress Large Anticoagulant Benefit in Elderly and Frail Patients with Atrial Fibrillation

ARIADNE Real-World Study: Confirming Outcomes and Wellbeing of Patients with Chronic Heart Failure

Relapsing-Remitting Multiple Sclerosis and High-efficacy Therapies

Relapsing-Remitting Multiple Sclerosis: Oral First-line Immunomodulators

Next-Generation BTK Inhibitors Fulfilling Promise for CLL in Long-Term Follow-Up

Selective JAK Inhibitors Tested for Control of Psoriatic Arthritis

Practical Role of New Rheumatoid Arthritis Therapy Outlined in Expanded Data

Major Trials Alter Standards for Anticoagulant Therapy in PAD and Valve Replacement

HIV Patients with NAFLD Are at High Risk of Progressive Liver Fibrosis

Adequate Care across the Spectrum of Chronic Urticaria is in the Process of Redefinition

Chronic Spontaneous Urticaria Is Not an Allergic Process: The Limited Value of Extensive Testing